Masimo Corporation
Clinical trials sponsored by Masimo Corporation, explained in plain language.
A medical technology company known for noninvasive patient monitoring devices, including pulse oximetry.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New oxygen sensor tested for kids of all skin tones Results expected Dec 2026 (estimated)
-
Can a Stick-On sensor replace the thermometer?
Diagnosis Stopped earlyThis trial tests how well a new noninvasive sensor, called Masimo INVSENSOR00048, measures body temperature compared to standard thermometers. It includes people of all ages, both with and without fever. The goal is to see if the sensor's readings are accurate enough for clinical…
Sponsor: Masimo Corporation • Aim: Diagnosis
Last updated Aug 27, 2026 00:00 UTC
-
Can a sticker on the chest replace the thermometer?
Diagnosis Stopped earlyThis trial evaluates a new noninvasive sensor that sticks to the skin to measure body temperature. It involves adults with fever, comparing the sensor's readings to a standard reference thermometer. The goal is to see how closely the sensor matches the reference, which could lead…
Sponsor: Masimo Corporation • Aim: Diagnosis
Last updated Aug 27, 2026 00:00 UTC
-
Can a simple device ease opioid withdrawal?
Symptom relief Stopped earlyThis study tested a device called Bridge to see if it could reduce symptoms of opioid withdrawal. Researchers compared it to a fake device in 13 adults with opioid use disorder. The study was stopped early, so results are limited.
Sponsor: Masimo Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Pain relief device study for hip surgery halted early
Symptom relief Stopped earlyThis study looked at whether a device called the Bridge system could help manage pain after hip replacement surgery. Only 5 people took part before the study was stopped early, so the results are not reliable. The goal was to see if the device could reduce the need for painkiller…
Sponsor: Masimo Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New sensor aims to take the guesswork out of IV fluids during surgery
Knowledge-focused Stopped earlyThis study tested a new sensor measure called RPVi to see if it can predict how patients will respond to fluids during surgery. Researchers compared RPVi to standard methods in 63 adults having elective surgery. The study was terminated early, so the findings are limited.
Sponsor: Masimo Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New finger sensor aims to reduce blood transfusions in surgery
Knowledge-focused Stopped earlyThis study tested a special finger sensor that measures hemoglobin and fluid levels without needles during surgery. The goal was to see if this real-time information helps doctors decide when to give blood transfusions, potentially reducing the amount of donor blood needed. The s…
Sponsor: Masimo Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC